Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ADAMS STREET PARTNERS LLC

Q2 2023 · 13F-HR

ADAMS STREET PARTNERS LLCholdings as filed

Filed 2023-08-14 · accession 0001104659-23-091158

$382.4M
Reported value
18
Positions
2023-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
76674Q107RMNIRimini Street, Inc.$112.9M29.5%23,565,433CommonSOLE
70438V106PCTYPaylocity Holding Corporation$108.3M28.3%586,902CommonSOLE
603170101MLYSMineralys Therapeutics, Inc.$41.3M10.8%2,419,501CommonSOLE
74736L109QTWOQ2 Holdings, Inc.$24.0M6.28%777,562CommonSOLE
45114M109Icosavax, Inc.$21.7M5.66%2,180,864CommonSOLE
36118A100Fusion Pharmaceuticals, Inc.$13.8M3.60%2,947,809CommonSOLE
98980F104GTMZoomInfo Technologies Inc.$13.2M3.46%520,631CommonSOLE
91854V107Vacasa, Inc.$12.8M3.34%18,764,501CommonSOLE
20717M1038QRConfluent, Inc.$7.5M1.97%213,798CommonSOLE
221015100CRVSCorvus Pharmaceuticals, Inc.$7.5M1.96%3,275,616CommonSOLE
90364P105PATHUiPath, Inc.$5.9M1.54%355,775CommonSOLE
770700102HOODRobinhood Markets, Inc.$4.8M1.26%482,220CommonSOLE
302492103FLYWFlywire Corporation$4.6M1.20%147,336CommonSOLE
74340E103PGNYProgyny, Inc.$1.2M0.31%29,858CommonSOLE
79589L106IOTSamsara, Inc.$1.0M0.27%36,681CommonSOLE
604749101MIRMMirum Pharmaceuticals, Inc.$772,1940.20%29,849CommonSOLE
03940C100ACLXGBXArcellx, Inc.$724,8570.19%22,924CommonSOLE
358054104FRSHFreshworks Inc.$535,2760.14%30,448CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.